Krystal Biotech Inc (KRYS): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 395,444 US Dollar | 10 | 1 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 29.598.836 | 16,24 | 9,85 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Krystal Biotech Inc
Mitarbeiter 295
Handelsplatz NASDAQ
Ticker Symbol KRYS
IPO Datum 2017-09-20
Adresse 2100 Wharton Street, Pittsburgh, PA, United States, 15203
Webseite https://www.krystalbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Krish S. Krishnan M.B.A., M.S. | Founder, Chairman, President & CEO |
| 2 | Ms. Suma M. Krishnan | Founder, President of R&D and Director |
| 3 | Ms. Kathryn A. Romano CPA | Executive VP & Chief Accounting Officer |
| 4 | Mr. John C. Thomas | EVP, General Counsel & Corporate Secretary |
| 5 | Mr. John Karakkal | Vice President of North American Sales & Marketing |
| 6 | Dr. Stephane Paquette Ph.D. | Senior Vice President of Corporate Development |
| 7 | Mr. Josh Suskin | Senior Director & Head of US Human Resources |
| 8 | Mr. Laurent Goux | Executive VP & Head of International |
| 9 | Dr. David Chien M.D. | Senior Vice President of Clinical Development |
| 10 | Ms. Christine Wilson | Senior VP & Head of US Commercial |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,93% | 1,42 Mrd. USD |
| 2 | BlackRock Inc | 14,13% | 1,34 Mrd. USD |
| 3 | venBio Select Advisor LLC | 9,76% | 0,93 Mrd. USD |
| 4 | Vanguard Portfolio Management, LLC | 5,32% | 0,51 Mrd. USD |
| 5 | State Street Corp | 4,56% | 0,43 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 4,19% | 0,40 Mrd. USD |
| 7 | Soleus Capital Management, L.P. | 3,17% | 0,30 Mrd. USD |
| 8 | Capital World Investors | 2,63% | 0,25 Mrd. USD |
| 9 | Vestor Capital Partners | 2,37% | 0,23 Mrd. USD |
| 10 | Geode Capital Management, LLC | 2,36% | 0,23 Mrd. USD |
| 11 | T. Rowe Price Associates, Inc. | 2,32% | 0,22 Mrd. USD |
| 12 | Hood River Capital Management LLC | 2,24% | 0,21 Mrd. USD |
| 13 | Redmile Group, LLC | 2,14% | 0,20 Mrd. USD |
| 14 | William Blair Investment Management, LLC | 1,93% | 0,18 Mrd. USD |
| 15 | Frazier Life Sciences Management, L.P. | 1,63% | 0,16 Mrd. USD |
| 16 | Dimensional Fund Advisors, Inc. | 1,61% | 0,15 Mrd. USD |
| 17 | First Trust Advisors L.P. | 1,10% | 0,10 Mrd. USD |
| 18 | Amvescap Plc. | 1,10% | 0,10 Mrd. USD |
| 19 | The Goldman Sachs Group Inc | 1,01% | 0,10 Mrd. USD |
| 20 | Northern Trust Corp | 0,96% | 0,09 Mrd. USD |